TY - JOUR AU - Straten, A. AU - Damme, L. AU - Haberer, J. E. AU - Bangsberg, D. R. PY - 2012 DA - 2012// TI - Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention JO - AIDS VL - 26 UR - https://doi.org/10.1097/QAD.0b013e3283522272 DO - 10.1097/QAD.0b013e3283522272 ID - Straten2012 ER - TY - JOUR AU - Masse, B. R. AU - Boily, M. C. AU - Dimitrov, D. AU - Desai, K. PY - 2009 DA - 2009// TI - Efficacy dilution in randomized placebo-controlled vaginal microbicide trials JO - Emerg Themes Epidemiol VL - 6 UR - https://doi.org/10.1186/1742-7622-6-5 DO - 10.1186/1742-7622-6-5 ID - Masse2009 ER - TY - JOUR AU - Karim, Q. A. AU - Baxter, C. AU - Karim, S. A. PY - 2014 DA - 2014// TI - Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies JO - BJOG VL - 121 UR - https://doi.org/10.1111/1471-0528.12843 DO - 10.1111/1471-0528.12843 ID - Karim2014 ER - TY - JOUR AU - Celum, C. AU - Baeten, J. M. PY - 2012 DA - 2012// TI - Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence JO - Curr Opin Infect Dis VL - 25 UR - https://doi.org/10.1097/QCO.0b013e32834ef5ef DO - 10.1097/QCO.0b013e32834ef5ef ID - Celum2012 ER - TY - JOUR AU - Anderson, P. L. AU - Kiser, J. J. AU - Gardner, E. M. AU - Rower, J. E. AU - Meditz, A. AU - Grant, R. M. PY - 2011 DA - 2011// TI - Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection JO - J Antimicrob Chemother VL - 66 UR - https://doi.org/10.1093/jac/dkq447 DO - 10.1093/jac/dkq447 ID - Anderson2011 ER - TY - JOUR AU - Baeten, J. M. AU - Donnell, D. AU - Ndase, P. AU - Mugo, N. R. AU - Campbell, J. D. AU - Wangisi, J. AU - Tappero, J. W. AU - Bukusi, E. A. AU - Cohen, C. R. AU - Katabira, E. PY - 2012 DA - 2012// TI - Antiretroviral prophylaxis for HIV prevention in heterosexual men and women JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1108524 DO - 10.1056/NEJMoa1108524 ID - Baeten2012 ER - TY - JOUR AU - Grant, R. M. AU - Lama, J. R. AU - Anderson, P. L. AU - McMahan, V. AU - Liu, A. Y. AU - Vargas, L. AU - Goicochea, P. AU - Casapia, M. AU - Guanira-Carranza, J. V. AU - Ramirez-Cardich, M. E. PY - 2010 DA - 2010// TI - Preexposure chemoprophylaxis for HIV prevention in men who have sex with men JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1011205 DO - 10.1056/NEJMoa1011205 ID - Grant2010 ER - TY - JOUR AU - Hendrix, C. W. AU - Chen, B. A. AU - Guddera, V. AU - Hoesley, C. AU - Justman, J. AU - Nakabiito, C. AU - Salata, R. AU - Soto-Torres, L. AU - Patterson, K. AU - Minnis, A. M. PY - 2013 DA - 2013// TI - MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0055013 DO - 10.1371/journal.pone.0055013 ID - Hendrix2013 ER - TY - JOUR AU - Baeten, J. M. AU - Haberer, J. E. AU - Liu, A. Y. AU - Sista, N. PY - 2013 DA - 2013// TI - Preexposure prophylaxis for HIV prevention: where have we been and where are we going? JO - JAIDS J Acquir Immune Defici Syndr VL - 63 UR - https://doi.org/10.1097/QAI.0b013e3182986f69 DO - 10.1097/QAI.0b013e3182986f69 ID - Baeten2013 ER - TY - JOUR AU - Marrazzo, J. M. AU - Ramjee, G. AU - Richardson, B. A. AU - Gomez, K. AU - Mgodi, N. AU - Nair, G. AU - Palanee, T. AU - Nakabiito, C. AU - Straten, A. AU - Noguchi, L. PY - 2015 DA - 2015// TI - Tenofovir-based preexposure prophylaxis for HIV infection among African women JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1402269 DO - 10.1056/NEJMoa1402269 ID - Marrazzo2015 ER - TY - CHAP AU - Rees, H. AU - Delany-Morelwe, S. AU - Lombard, C. PY - 2015 DA - 2015// TI - FACTS 001 phase III trial of pericoital tenofovir 1% gel for HIV prevention in women BT - Conference on retroviruses and opportunistic infections (CROI): 2015 ID - Rees2015 ER - TY - JOUR AU - Damme, L. AU - Corneli, A. AU - Ahmed, K. AU - Agot, K. AU - Lombaard, J. AU - Kapiga, S. AU - Malahleha, M. AU - Owino, F. AU - Manongi, R. AU - Onyango, J. PY - 2012 DA - 2012// TI - Preexposure prophylaxis for HIV infection among African women JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1202614 DO - 10.1056/NEJMoa1202614 ID - Damme2012 ER - TY - STD TI - Koss CA, Bacchetti P, Hillier SL, Livant E, Horng H, Mgodi N, Mirembe BG, Gomez Feliciano K, Horn S, Liu AY, et al. Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations. AIDS Res Hum Retroviruses. 2017;00(00):1-6. ID - ref13 ER - TY - JOUR AU - Straten, A. AU - Montgomery, E. T. AU - Musara, P. AU - Etima, J. AU - Naidoo, S. AU - Laborde, N. AU - Hartmann, M. AU - Levy, L. AU - Bennie, T. AU - Cheng, H. PY - 2015 DA - 2015// TI - Disclosure of pharmacokinetic drug results to understand nonadherence JO - AIDS VL - 29 UR - https://doi.org/10.1097/QAD.0000000000000801 DO - 10.1097/QAD.0000000000000801 ID - Straten2015 ER - TY - JOUR AU - Montgomery, E. T. AU - Mensch, B. AU - Musara, P. AU - Hartmann, M. AU - Woeber, K. AU - Etima, J. AU - Straten, A. PY - 2017 DA - 2017// TI - Misreporting of product adherence in the MTN-003/VOICE trial for HIV prevention in Africa: Participants' explanations for dishonesty JO - AIDS Behav VL - 21 UR - https://doi.org/10.1007/s10461-016-1609-1 DO - 10.1007/s10461-016-1609-1 ID - Montgomery2017 ER - TY - STD TI - Musara P, Montgomery ET, Mgodi NM, Woeber K, Akello CA, Hartmann M, Cheng H, Levy L, Katz A, Grossman CI, et al. How Presentation of Drug Detection Results Changed Reports of Product Adherence in South Africa, Uganda and Zimbabwe. AIDS Behav. 2018;22(3):877-86. ID - ref16 ER - TY - STD TI - Rossi L. Microbicide Trials Network Statement on Decision to Discontinue Use of Oral Tenofovir Tablets in VOICE, a Major HIV Prevention Study in Women. https://mtnstopshiv.org/news/mtn-statement-decision-discontinue-use-oral-tenofovir-tablets-voice-major-hiv-prevention-study; 2011. UR - https://mtnstopshiv.org/news/mtn-statement-decision-discontinue-use-oral-tenofovir-tablets-voice-major-hiv-prevention-study ID - ref17 ER - TY - STD TI - Rossi L. Microbicide Trials Network Statement on Decision to Discontinue Use of Tenofovir Gel in VOICE, a Major HIV Prevention Study in Women. In. https://mtnstopshiv.org/news/mtn-statement-decision-discontinue-use-tenofovir-gel-voice-major-hiv-prevention-study-women; 2011. UR - https://mtnstopshiv.org/news/mtn-statement-decision-discontinue-use-tenofovir-gel-voice-major-hiv-prevention-study-women ID - ref18 ER - TY - JOUR AU - Mensch, B. S. AU - Brown, E. R. AU - Liu, K. AU - Marrazzo, J. AU - Chirenje, Z. M. AU - Gomez, K. AU - Piper, J. AU - Patterson, K. AU - Straten, A. PY - 2016 DA - 2016// TI - Reporting of adherence in the VOICE trial: did disclosure of product nonuse increase at the termination visit? JO - AIDS Behav VL - 20 UR - https://doi.org/10.1007/s10461-016-1312-2 DO - 10.1007/s10461-016-1312-2 ID - Mensch2016 ER - TY - JOUR AU - Duby, Z. AU - Hartmann, M. AU - Mahaka, I. AU - Montgomery, E. T. AU - Colvin, C. J. AU - Mensch, B. AU - Straten, A. PY - 2014 DA - 2014// TI - Language, terminology and understanding of anal sex amongst VOICE participants in Uganda, Zimbabwe and South Africa JO - AIDS Res Hum Retrovir VL - 30 UR - https://doi.org/10.1089/aid.2014.5009.abstract DO - 10.1089/aid.2014.5009.abstract ID - Duby2014 ER - TY - STD TI - Duby Z, Hartmann M, Montgomery ET, Colvin CJ, Mensch B, van der Straten A. Condoms, Lubricants and Rectal Cleansing: Practices Associated with Heterosexual Penile-Anal Intercourse Amongst Participants in an HIV Prevention Trial in South Africa, Uganda and Zimbabwe. AIDS Behav. 2016;20(4):754-62. ID - ref21 ER - TY - STD TI - Duby Z, Hartmann M, Montgomery ET, Colvin CJ, Mensch B, van der Straten A. Sexual scripting of heterosexual penile-anal intercourse amongst participants in an HIV prevention trial in South Africa, Uganda and Zimbabwe. Cult Health Sex. 2016;18(1):30-44. ID - ref22 ER - TY - JOUR AU - Minnis, A. M. AU - Straten, A. AU - Salee, P. AU - Hendrix, C. W. PY - 2016 DA - 2016// TI - Pre-exposure prophylaxis adherence measured by plasma drug level in MTN-001: comparison between vaginal gel and Oral tablets in two geographic regions JO - AIDS Behav VL - 20 UR - https://doi.org/10.1007/s10461-015-1081-3 DO - 10.1007/s10461-015-1081-3 ID - Minnis2016 ER - TY - STD TI - Wong C, Parker C, Ahmed K, Agot K, Skhosana J, Odhiambo J, Makatu S, Lemons A, Mueller M, Van Damme L et al. Participant motivation for enrolling and continuing in the FEM-PrEP HIV prevention clinical trial. In: IAS: 2013; Kuala Lumpur, Malaysia; 2013. ID - ref24 ER - TY - JOUR AU - Mensch, B. S. AU - Friedland, B. A. AU - Abbott, S. A. AU - Katzen, L. L. AU - Tun, W. AU - Kelly, C. A. AU - Sarna, A. AU - Srikrishnan, A. K. AU - Solomon, S. PY - 2013 DA - 2013// TI - Characteristics of female sex workers in southern India willing and unwilling to participate in a placebo gel trial JO - AIDS Behav VL - 17 UR - https://doi.org/10.1007/s10461-012-0259-1 DO - 10.1007/s10461-012-0259-1 ID - Mensch2013 ER - TY - JOUR AU - McCann, S. K. AU - Campbell, M. K. AU - Entwistle, V. A. PY - 2010 DA - 2010// TI - Reasons for participating in randomised controlled trials: conditional altruism and considerations for self JO - Trials VL - 11 UR - https://doi.org/10.1186/1745-6215-11-31 DO - 10.1186/1745-6215-11-31 ID - McCann2010 ER - TY - STD TI - Giguere R, Zimet GD, Kahn JA, Dolezal C, Leu C-S, Mabragaña M, McGowan I, Carballo-Diéguez A. The Motivations and Experiences of Young Women in a Microbicide Trial in the USA and Puerto Rico. World journal of AIDS. 2013;3(3):1-12. ID - ref27 ER - TY - JOUR AU - Meque, I. AU - Dube, K. AU - Bierhuizen, L. AU - Zango, A. AU - Veldhuijzen, N. AU - Cumbe, F. AU - Feldblum, P. J. AU - Wijgert, J. PY - 2014 DA - 2014// TI - Willingness to participate in future HIV prevention trials in Beira, Mozambique JO - Afr J AIDS Res VL - 13 UR - https://doi.org/10.2989/16085906.2014.985239 DO - 10.2989/16085906.2014.985239 ID - Meque2014 ER - TY - JOUR AU - Tharawan, K. AU - Manopaiboon, C. AU - Ellertson, C. AU - Limpakarnjanarat, K. AU - Chaikummao, S. AU - Kilmarx, P. H. AU - Blanchard, K. AU - Coggins, C. AU - Mastro, T. D. AU - Elias, C. PY - 2001 DA - 2001// TI - Women's willingness to participate in microbicide trials in northern Thailand JO - J Acquir Immune Defic Syndr (1999) VL - 28 UR - https://doi.org/10.1097/00126334-200110010-00011 DO - 10.1097/00126334-200110010-00011 ID - Tharawan2001 ER - TY - JOUR AU - Thienkrua, W. AU - Todd, C. S. AU - Chaikummao, S. AU - Sukwicha, W. AU - Yafant, S. AU - Tippanont, N. AU - Varangrat, A. AU - Khlaimanee, P. AU - Holtz, T. H. PY - 2014 DA - 2014// TI - Prevalence and correlates of willingness to participate in a rectal microbicide trial among men who have sex with men in Bangkok JO - AIDS Care VL - 26 UR - https://doi.org/10.1080/09540121.2014.913763 DO - 10.1080/09540121.2014.913763 ID - Thienkrua2014 ER - TY - JOUR AU - Wendler, D. AU - Krohmal, B. AU - Emanuel, E. J. AU - Grady, C. PY - 2008 DA - 2008// TI - Why patients continue to participate in clinical research JO - Arch Intern Med VL - 168 UR - https://doi.org/10.1001/archinte.168.12.1294 DO - 10.1001/archinte.168.12.1294 ID - Wendler2008 ER - TY - BOOK PY - 2015 DA - 2015// TI - Consolidated guidelines on HIV testing services: 5Cs: consent, confidentiality, counselling, correct results and connection 2015 ID - ref32 ER - TY - BOOK PY - 2015 DA - 2015// TI - Fact sheet to the WHO consolidated guidelines on HIV testing services ID - ref33 ER - TY - JOUR AU - Dhalla, S. AU - Poole, G. PY - 2014 DA - 2014// TI - Motivators to participation in actual HIV vaccine trials JO - AIDS Behav VL - 18 UR - https://doi.org/10.1007/s10461-013-0519-8 DO - 10.1007/s10461-013-0519-8 ID - Dhalla2014 ER - TY - JOUR AU - Stadler, J. J. AU - Delany, S. AU - Mntambo, M. PY - 2008 DA - 2008// TI - Women's perceptions and experiences of HIV prevention trials in Soweto, South Africa JO - Soc Sci Med (1982) VL - 66 UR - https://doi.org/10.1016/j.socscimed.2007.08.021 DO - 10.1016/j.socscimed.2007.08.021 ID - Stadler2008 ER - TY - JOUR AU - Stirratt, M. J. AU - Gordon, C. M. PY - 2008 DA - 2008// TI - Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research JO - Curr HIV/AIDS Rep VL - 5 UR - https://doi.org/10.1007/s11904-008-0027-z DO - 10.1007/s11904-008-0027-z ID - Stirratt2008 ER - TY - JOUR AU - Macphail, C. AU - Delany-Moretlwe, S. AU - Mayaud, P. PY - 2012 DA - 2012// TI - It's not about money, it's about my health': determinants of participation and adherence among women in an HIV-HSV2 prevention trial in Johannesburg, South Africa JO - Patient Prefer Adherence VL - 6 UR - https://doi.org/10.2147/PPA.S30759 DO - 10.2147/PPA.S30759 ID - Macphail2012 ER - TY - JOUR AU - Akinyemiju, T. F. AU - McDonald, J. A. AU - Lantz, P. M. PY - 2015 DA - 2015// TI - Health care access dimensions and cervical cancer screening in South Africa: analysis of the world health survey JO - BMC Public Health VL - 15 UR - https://doi.org/10.1186/s12889-015-1686-5 DO - 10.1186/s12889-015-1686-5 ID - Akinyemiju2015 ER - TY - JOUR AU - Chandler, C. I. R. AU - Kizito, J. AU - Taaka, L. AU - Nabirye, C. AU - Kayendeke, M. AU - DiLiberto, D. AU - Staedke, S. G. PY - 2013 DA - 2013// TI - Aspirations for quality health care in Uganda: how do we get there? JO - Hum Resour Health VL - 11 UR - https://doi.org/10.1186/1478-4491-11-13 DO - 10.1186/1478-4491-11-13 ID - Chandler2013 ER - TY - STD TI - Chevo T, Bhatasara S. HIV and AIDS Programmes in Zimbabwe: implications for the health system. ISRN Immunology 2012, 2012:11. ID - ref40 ER - TY - JOUR AU - Musheke, M. AU - Ntalasha, H. AU - Gari, S. AU - Mckenzie, O. AU - Bond, V. AU - Martin-Hilber, A. AU - Merten, S. PY - 2013 DA - 2013// TI - A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in sub-Saharan Africa JO - BMC Public Health VL - 13 UR - https://doi.org/10.1186/1471-2458-13-220 DO - 10.1186/1471-2458-13-220 ID - Musheke2013 ER - TY - JOUR AU - Mayosi, B. M. AU - Benatar, S. R. PY - 2014 DA - 2014// TI - Health and health Care in South Africa — 20 years after Mandela JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMsr1405012 DO - 10.1056/NEJMsr1405012 ID - Mayosi2014 ER - TY - JOUR AU - Lie, R. K. AU - Emanuel, E. AU - Grady, C. AU - Wendler, D. PY - 2004 DA - 2004// TI - The standard of care debate: the declaration of Helsinki versus the international consensus opinion JO - J Med Ethics VL - 30 UR - https://doi.org/10.1136/jme.2003.006031 DO - 10.1136/jme.2003.006031 ID - Lie2004 ER - TY - JOUR AU - Marouf, F. E. AU - Esplin, B. S. PY - 2015 DA - 2015// TI - Setting a minimum standard of Care in Clinical Trials: human rights and bioethics as complementary frameworks JO - Health Hum Rights VL - 17 UR - https://doi.org/10.2307/healhumarigh.17.1.31 DO - 10.2307/healhumarigh.17.1.31 ID - Marouf2015 ER - TY - JOUR AU - Resnik, D. B. AU - Ness, E. PY - 2012 DA - 2012// TI - Participants’ responsibilities in clinical research JO - J Med Ethics VL - 38 UR - https://doi.org/10.1136/medethics-2011-100319 DO - 10.1136/medethics-2011-100319 ID - Resnik2012 ER - TY - STD TI - Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, Matovu Kiweewa F, Nair G, Mhlanga F, et al. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. N Engl J Med. 2016;375(22):2121-32. ID - ref46 ER - TY - JOUR AU - Montgomery, E. T. AU - Straten, A. AU - Chitukuta, M. AU - Reddy, K. AU - Woeber, K. AU - Atujuna, M. AU - Bekker, L. G. AU - Etima, J. AU - Nakyanzi, T. AU - Mayo, A. J. PY - 2017 DA - 2017// TI - Acceptability and use of a dapivirine vaginal ring in a phase III trial JO - Aids VL - 31 UR - https://doi.org/10.1097/QAD.0000000000001452 DO - 10.1097/QAD.0000000000001452 ID - Montgomery2017 ER - TY - JOUR AU - Amico, K. R. AU - Wallace, M. AU - Bekker, L. G. AU - Roux, S. AU - Atujuna, M. AU - Sebastian, E. AU - Dye, B. J. AU - Elharrar, V. AU - Grant, R. M. PY - 2017 DA - 2017// TI - Experiences with HPTN 067/ADAPT study-provided open-label PrEP among women in Cape Town: facilitators and barriers within a mutuality framework JO - AIDS Behav VL - 21 UR - https://doi.org/10.1007/s10461-016-1458-y DO - 10.1007/s10461-016-1458-y ID - Amico2017 ER - TY - JOUR AU - Sivaram, S. AU - Zelaya, C. AU - Srikrishnan, A. K. AU - Latkin, C. AU - Go, V. F. AU - Solomon, S. AU - Celentano, D. PY - 2009 DA - 2009// TI - Associations between social capital and HIV stigma in Chennai, India: considerations for prevention intervention design JO - AIDS Educ Prev VL - 21 UR - https://doi.org/10.1521/aeap.2009.21.3.233 DO - 10.1521/aeap.2009.21.3.233 ID - Sivaram2009 ER - TY - JOUR AU - Vyas, S. AU - Kumaranayake, L. PY - 2006 DA - 2006// TI - Constructing socio-economic status indices: how to use principal components analysis JO - Health Policy Plan VL - 21 UR - https://doi.org/10.1093/heapol/czl029 DO - 10.1093/heapol/czl029 ID - Vyas2006 ER - TY - JOUR AU - Luecke, E. H. AU - Cheng, H. AU - Woeber, K. AU - Nakyanzi, T. AU - Mudekunye-Mahaka, I. C. AU - Straten, A. PY - 2016 DA - 2016// TI - Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study JO - J Int AIDS Soc VL - 19 UR - https://doi.org/10.7448/IAS.19.1.20875 DO - 10.7448/IAS.19.1.20875 ID - Luecke2016 ER -